Related Experiment Video
Updated: Jul 29, 2025
08:10
The 6-hydroxydopamine Rat Model of Parkinson's Disease
Published on: October 27, 2021
10.9K
Parkinson's Disease: Exploring Different Animal Model Systems.
Engila Khan1, Ikramul Hasan2, M Emdadul Haque1,3
1Department of Biochemistry and Molecular Biology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
International Journal of Molecular Sciences
|May 27, 2023
Summary
This review discusses animal models for Parkinson's disease research. It covers common models, their applications, and limitations in understanding this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Pathology
- Pharmacology
Background:
- Parkinson's disease is a progressive neurodegenerative disorder.
- Pathological hallmarks include alpha-synuclein aggregation and dopaminergic neuron loss.
- Understanding disease etiology and pathophysiology requires robust experimental models.
Purpose of the Study:
- To review and discuss commonly used animal models for Parkinson's disease.
- To highlight the applications of these models in research.
- To outline the limitations of current Parkinson's disease animal models.
Main Methods:
- Review of existing literature on Parkinson's disease animal models.
- Discussion of models induced pharmacologically.
- Discussion of models created via genetic manipulation.
Main Results:
- Various animal models exist for Parkinson's disease research.
- Models are tailored based on disease pathophysiology and prognosis.
- Both pharmacological and genetic induction methods are employed.
Conclusions:
- Animal models are crucial for studying Parkinson's disease.
- Common models involve pharmacological or genetic induction.
- Understanding model limitations is key for accurate research outcomes.
Related Concept Videos
01:15Parkinson's Disease: Overview
614
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
614
01:24Parkinson's Disease: Treatment
308
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
308
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:37Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K